Publications Authored by Federica Gemignani

Ludwig Institute for Cancer Research, University of Oxford, Nuffield Department of Clinical Medicine, Old Road Campus Research Building, Oxford OX3 7DQ, UK.

View Article

April 2016

Targeting hypoxic response for cancer therapy.

Authors:

Elisa Paolicchi Federica Gemignani Marija Krstic-Demonacos Shoukat Dedhar Luciano Mutti Stefano Landi

Oncotarget 2016 Mar;7(12):13464-78

Genetics-Department of Biology, University of Pisa, Pisa, Italy.

View Article

March 2016

Runs of homozygosity and inbreeding in thyroid cancer.

Authors:

Hauke Thomsen Bowang Chen Gisella Figlioli Rossella Elisei Cristina Romei Monica Cipollini Alfonso Cristaudo Franco Bambi Per Hoffmann Stefan Herms Stefano Landi Kari Hemminki Federica Gemignani Asta Försti

BMC Cancer 2016 Mar 16;16:227. Epub 2016 Mar 16.

Molecular Genetic Epidemiology, C050, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120, Heidelberg, Germany.

View Article

March 2016

Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium.

Endocr Relat Cancer 2015 Aug 22;22(4):545-59. Epub 2015 Jun 22.

Genomic Oncology AreaGENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, SpainHematology DepartmentVirgen de las Nieves University Hospital, Granada, SpainGenomic Epidemiology GroupGerman Cancer Research Center (DKFZ), Heidelberg, GermanyDepartment of BiologyUniversity of Pisa, Pisa, ItalyDepartment of HematologyHospital Universitario Doce de Octubre, Madrid, SpainArea of Genomic MedicineGENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, SpainSemmelweis UniversityBudapest, HungaryHaematology DepartmentUniversity Hospital of Salamanca and IBSAL, Salamanca, SpainMedical University of LodzLodz, PolandINSERM UMR 1052/CNRS 5286Université Claude Bernard Lyon I, Lyon, FranceMorales Meseguer General University HospitalMurcia, SpainHaematoloy ClinikHolly Cross Cancer Center, Kielce, PolandINSERMU900, Genetic Epidemiology of Cancers team, Institut Curie, Mines ParisTech, Paris, FranceLife and Health Sciences Research Institute (ICVS)School of Health Sciences, University of Minho, Braga, PortugalICVS/3B's - PT Government Associate LaboratoryBraga/Guimarães, PortugalMolecular Oncology Research CenterBarretos Cancer Hospital, Barretos, BrazilIDIBELL - Catalan Institute of OncologyUniversity of Barcelona, Barcelona 08907, SpainDepartment of HematologyCracow University Hospital, Cracow, PolandOrgan CenterHospital of Southern Jutland, DK-6200 Aabenraa, DenmarkFaculty of Health SciencesInstitute of Regional Health Research, University of Southern Denmark, DK-5000 Odense C, DenmarkUO HematologyDepartment of Internal and Experimental Medicine, University of Pisa, Pisa, ItalyClinic of Biochemistry and ImmunologyLaboratory Center, Hospital of Southern Jutland, Aabenraa, DenmarkDepartment of HaematologyRigshospitalet and Roskilde Hospital, Copenhagen University, Copenhagen, Denmark Genomic Oncology AreaGENYO, Cen

View Article

August 2015

Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length.

Int J Cancer 2015 Mar 6;136(5):E351-8. Epub 2014 Aug 6.

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

View Article

March 2015

Novel genetic variants in differentiated thyroid cancer and assessment of the cumulative risk.

Sci Rep 2015 Mar 10;5:8922. Epub 2015 Mar 10.

1] Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany [2] Center for Primary Health Care Research, Clinical Research Center, Lund University, Malmö, Sweden.

View Article

March 2015

Expression status of candidate genes in mesothelioma tissues and cell lines.

Authors:

Ombretta Melaiu Erika Melissari Luciano Mutti Elisa Bracci Chiara De Santi Caterina Iofrida Manuela Di Russo Alfonso Cristaudo Alessandra Bonotti Monica Cipollini Sonia I Garritano Rudy Foddis Marco Lucchi Silvia Pellegrini Federica Gemignani Stefano Landi

Mutat Res 2015 Jan 13;771:6-12. Epub 2014 Nov 13.

Department of Biology, University of Pisa, Pisa 56126, Italy.

View Article

January 2015

A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people.

Authors:

Sonia Garritano Chiara De Santi Roberto Silvestri Ombretta Melaiu Monica Cipollini Elisa Barone Marco Lucchi Roberto Barale Luciano Mutti Federica Gemignani Alessandra Bonotti Rudy Foddis Alfonso Cristaudo Stefano Landi

J Thorac Oncol 2014 Nov;9(11):1662-8

*Laboratory of Computational Oncology, Centre for Integrative Biology, CIBIO, University of Trento, Trento, Italy; †Department of Biology, University of Pisa, Pisa, Italy; ‡Division of Thoracic Surgery, Cardiac and Thoracic Department, University of Pisa, Pisa, Italy; §Department of Medicine, Vercelli Teaching Hospital, Vercelli, Italy; and ‖Section of Occupational Medicine, School of Medicine and Surgery, University of Pisa, Pisa, Italy.

View Article

November 2014

MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma.

Authors:

Ombretta Melaiu Justin Stebbing Ylenia Lombardo Elisa Bracci Norihisa Uehara Alessandra Bonotti Alfonso Cristaudo Rudy Foddis Luciano Mutti Roberto Barale Federica Gemignani Georgios Giamas Stefano Landi

PLoS One 2014 21;9(1):e85935. Epub 2014 Jan 21.

Department of Biology, University of Pisa, Pisa, Italy.

View Article

October 2014

Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk.

J Clin Endocrinol Metab 2014 Oct 16;99(10):E2084-92. Epub 2014 Jul 16.

Department of Biology (G.F., M.C., E.P., S.L., F.G.), University of Pisa, 56123 Pisa, Italy; Molecular Genetic Epidemiology (A.K., B.C., K.H., A.F.), German Cancer Research Center, 69120 Heidelberg, Germany; Department of Endocrinology and Metabolism (R.E., C.R., A.C.), University of Pisa, 56124 Pisa, Italy; Blood Centre (F.B.), Azienda Ospedaliero Universitaria A. Meyer, 50139 Firenze, Italy; Department of Genomics (P.H., S.H.), Life and Brain Center and Institute of Human Genetics (P.H., S.H.), University of Bonn, D-53127 Bonn, Germany; Division of Medical Genetics (P.H., S.H.), University Hospital Basel and Department of Biomedicine, University of Basel, CH-4058 Basel, Switzerland; Department of Nuclear Medicine and Endocrine Oncology (M.K., D.K., B.J.), Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, 44-101 Gliwice, Poland; Grup de Mutagènesi (S.P., R.M., A.V.), Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallés, Barcelona, Spain; Centro de Investigación Biomédica en Red y Epidemiologia y Salud Pública (S.P., R.M., A.V.), Instituto de Salud Carlos III, 28029 Madrid, Spain; and Center for Primary Health Care Research (K.H., A.F.), Clinical Research Center, Lund University, 205 02 Malmö, Sweden.

View Article

October 2014

MicroRNA binding site polymorphisms as biomarkers in cancer management and research.

Authors:

Monica Cipollini Stefano Landi Federica Gemignani

Pharmgenomics Pers Med 2014 23;7:173-91. Epub 2014 Jul 23.

Department of Biology, University of Pisa, Pisa, Italy.

View Article

August 2014

Obesity and the risk of papillary thyroid cancer: a pooled analysis of three case-control studies.

Authors:

Li Xu Matthias Port Stefano Landi Federica Gemignani Monica Cipollini Rossella Elisei Lilia Goudeva Jörg Andreas Müller Kai Nerlich Giovanni Pellegrini Christoph Reiners Cristina Romei Robert Schwab Michael Abend Erich M Sturgis

Thyroid 2014 Jun 5;24(6):966-74. Epub 2014 May 5.

1 Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center , Houston, Texas.

View Article

June 2014

Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations--an extensive replication of the associations from the candidate gene era.

Cancer Epidemiol Biomarkers Prev 2014 Apr 12;23(4):670-4. Epub 2014 Feb 12.

Authors' Affiliations: Genomic Epidemiology Group, Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Hematology, Cracow University Hospital, Cracow; Medical University of Łodz; Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, Łodz; Rzeszow Regional Hospital, Rzeszow; Holycross Cancer Center, Kielce, Poland; Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; Morales Meseguer General University Hospital, Murcia; University Hospital of Salamanca, Salamanca; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government; Hematology Department, Virgen de las Nieves University Hospital, Granada; IDIBELL-Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; Semmelweis University, Budapest, Hungary; Institut National de la Santé et de la Recherche Medicale (INSERM) UMR 1052/CNRS 5286, Université Claude Bernard Lyon I, Lyon; Genetic Epidemiology of Cancer team, INSERM, U900, Institut Curie, Mines ParisTech, Paris, France; Department of Biology, University of Pisa, Pisa, Italy; Clinic of Immunology, Laboratory Center, Hospital of Southern Jutland, Sønderborg; Organ Center, Hospital of Southern Jutland, Aabenraa; Institute of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense C; National Research Centre for the Working Environment, Copenhagen; Roskilde Hospital, Copenhagen University, Roskilde, Denmark; Life and Health Sciences Research Institute, University of Minho, Braga; ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal; UO Hematology, Department of Internal and Experimental Medicine, University of Pisa, Pisa, Italy; and Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.

View Article

April 2014

TPO genetic variants and risk of differentiated thyroid carcinoma in two European populations.

Authors:

Monica Cipollini Susana Pastor Federica Gemignani Juan Castell Sonia Garritano Alessandra Bonotti Josefina Biarnés Gisella Figlioli Cristina Romei Ricard Marcos Alfonso Cristaudo Rossella Elisei Stefano Landi Antonia Velázquez

Int J Cancer 2013 Dec 13;133(12):2843-51. Epub 2013 Jul 13.

Department of Biology, University of Pisa, Pisa, Italy.

View Article

December 2013

Risk of differentiated thyroid carcinoma and polymorphisms within the susceptibility cancer region 8q24.

Cancer Epidemiol Biomarkers Prev 2013 Nov 5;22(11):2121-5. Epub 2013 Sep 5.

Authors' Affiliations: Department of Biology, University of Pisa, Pisa; Center for Integrated Biology, University of Trento, Trento; Department of Endocrinology and Metabolism, Orthopaedics and Traumatology, Occupational Medicine, University of Pisa, Pisa; and Operative Unit of Laboratory of Clinical Chemistry Analyses, University Hospital of Cisanello, Pisa, Italy.

View Article

November 2013

Variation within 3'-UTRs of base excision repair genes and response to therapy in colorectal cancer patients: A potential modulation of microRNAs binding.

Authors:

Barbara Pardini Fabio Rosa Elisa Barone Cornelia Di Gaetano Jana Slyskova Jan Novotny Miroslav Levy Sonia Garritano Ludmila Vodickova Tomas Buchler Federica Gemignani Stefano Landi Pavel Vodicka Alessio Naccarati

Clin Cancer Res 2013 Nov 13;19(21):6044-56. Epub 2013 Sep 13.

Authors' Affiliations: Human Genetics Foundation Torino; Department of Medical Sciences, University of Turin, Turin; Department of Biology, University of Pisa, Pisa; Laboratory of Computational Oncology, Center for Integrated Biology (CIBIO), University of Trento, Trento, Italy; Department of Molecular Biology of Cancer, Institute of Experimental Medicine; Departments of Surgery and Oncology, Thomayer Hospital; Institute of Biology and Department of Medical Genetics; and Department of Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic.

View Article

November 2013

Genome-wide association study on differentiated thyroid cancer.

J Clin Endocrinol Metab 2013 Oct 26;98(10):E1674-81. Epub 2013 Jul 26.

PhD, Division of Molecular Genetic Epidemiology, German Cancer Research Center, Im Neuenheimer Feld 580, 69120 Heidelberg, Germany.

View Article

October 2013

MAP3K7 and GSTZ1 are associated with human longevity: a two-stage case-control study using a multilocus genotyping.

Authors:

Fausta Di Cianni Daniele Campa Federica Tallaro Cosmeri Rizzato Francesco De Rango Roberto Barale Giuseppe Passarino Federico Canzian Federica Gemignani Alberto Montesanto Stefano Landi Giuseppina Rose

Age (Dordr) 2013 Aug 11;35(4):1357-66. Epub 2012 May 11.

Department of Cell Biology, University of Calabria, 87036, Rende, Italy.

View Article

August 2013

Medullary thyroid carcinoma (MTC) and RET proto-oncogene: mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form.

Authors:

Gisella Figlioli Stefano Landi Cristina Romei Rossella Elisei Federica Gemignani

Mutat Res 2013 Jan-Mar;752(1):36-44. Epub 2012 Oct 8.

Department of Biology, University of Pisa, Italy.

View Article

April 2013

Polymorphisms in regulators of xenobiotic transport and metabolism genes PXR and CAR do not affect multiple myeloma risk: a case-control study in the context of the IMMEnSE consortium.

Authors:

Alessandro Martino Juan Sainz Rui Manuel Reis Victor Moreno Gabriele Buda Fabienne Lesueur Herlander Marques Ramón García-Sanz Rafael Ríos Angelika Stein Charles Dumontet Federica Gemignani Anna Maria Rossi Stefano Landi Manuel Jurado Mario Petrini Krzysztof Jamroziak Daniele Campa Federico Canzian

J Hum Genet 2013 Mar 10;58(3):155-9. Epub 2013 Jan 10.

Genomic Epidemiology Group, German Cancer Research Center DKFZ, Heidelberg, Germany.

View Article

March 2013

Identification of candidate genes carrying polymorphisms associated with the risk of colorectal cancer by analyzing the colorectal mutome and microRNAome.

Authors:

Debora Landi Federica Gemignani Barbara Pardini Alessio Naccarati Sonia Garritano Pavel Vodicka Ludmila Vodickova Federico Canzian Jan Novotny Roberto Barale Stefano Landi

Cancer 2012 Oct 26;118(19):4670-80. Epub 2012 Jan 26.

Department of Biology, University of Pisa, Pisa, Italy.

View Article

October 2012

A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma.

Authors:

Ombretta Melaiu Alfonso Cristaudo Erika Melissari Manuela Di Russo Alessandra Bonotti Rossella Bruno Rudy Foddis Federica Gemignani Silvia Pellegrini Stefano Landi

Mutat Res 2012 Apr-Jun;750(2):132-40. Epub 2011 Dec 15.

Department of Biology, University of Pisa, Italy.

View Article

September 2012

Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma.

Br J Haematol 2012 Sep 24;158(6):805-9. Epub 2012 Jul 24.

View Article

September 2012

Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortium.

Br J Haematol 2012 May 13;157(3):331-8. Epub 2012 Feb 13.

Genomic Epidemiology Group, German Cancer Research Center DKFZ, Heidelberg, Germany.

View Article

May 2012

Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review).

Int J Oncol 2012 Mar 6;40(3):625-38. Epub 2011 Dec 6.

German Cancer Research Center, Genomic Epidemiology Group, Heidelberg, Germany.

View Article

March 2012

Role of variations within microRNA-binding sites in cancer.

Authors:

Debora Landi Federica Gemignani Stefano Landi

Mutagenesis 2012 Mar;27(2):205-10

Department of Biology, University of Pisa, Via Derna 1, 56100 Pisa, Italy.

View Article

March 2012

Polymorphisms affecting micro-RNA regulation and associated with the risk of dietary-related cancers: a review from the literature and new evidence for a functional role of rs17281995 (CD86) and rs1051690 (INSR), previously associated with colorectal cancer.

Authors:

Debora Landi Victor Moreno Elisabeth Guino Pavel Vodicka Barbara Pardini Alessio Naccarati Federico Canzian Roberto Barale Federica Gemignani Stefano Landi

Mutat Res 2011 Dec 30;717(1-2):109-15. Epub 2010 Oct 30.

Dipartimento di Biologia, University of Pisa, Pisa, Italy.

View Article

December 2011

Evidences that the polymorphism Pro-282-Ala within the tumor suppressor gene WWOX is a new risk factor for differentiated thyroid carcinoma.

Authors:

Lisa Cancemi Cristina Romei Sara Bertocchi Giulia Tarrini Irene Spitaleri Monica Cipollini Debora Landi Sonia Garritano Giovanni Pellegrini Alfonso Cristaudo Aldo Pinchera Roberto Barale Rossella Elisei Stefano Landi Federica Gemignani

Int J Cancer 2011 Dec 25;129(12):2816-24. Epub 2011 Apr 25.

Department of Biology, University of Pisa, Pisa, Italy.

View Article

December 2011

Two novel polymorphisms in 5' flanking region of the mesothelin gene are associated with soluble mesothelin-related peptide (SMRP) levels.

Authors:

Alfonso Cristaudo Rudy Foddis Alessandra Bonotti Silvia Simonini Agnese Vivaldi Giovanni Guglielmi Rossella Bruno Federica Gemignani Stefano Landi

Int J Biol Markers 2011 Apr-Jun;26(2):117-23

Department of Endocrinology and Metabolism, Orthopedics and Traumatology, Occupational Medicine, University of Pisa - Italy.

View Article

October 2011

Prediction of the biological effect of polymorphisms within microRNA binding sites.

Authors:

Debora Landi Roberto Barale Federica Gemignani Stefano Landi

Methods Mol Biol 2011 ;676:197-210

Genetics, Department of Biology, University of Pisa, Pisa, Italy.

View Article

January 2011

COMPASSS (COMplex PAttern of Sequence Search Software), a simple and effective tool for mining complex motifs in whole genomes.

Authors:

Giuseppe Maccari Federica Gemignani Stefano Landi

Bioinformatics 2010 Jul 25;26(14):1777-8. Epub 2010 May 25.

Laboratory of Microbiology and Genetics - Ospedale di Circolo e Fondazione Macchi, University of Insubria, Viale Borri 57 21100 Varese, Italy.

View Article

July 2010

Polymorphisms in the putative micro-RNA-binding sites of mesothelin gene are associated with serum levels of mesothelin-related protein.

Authors:

Alfonso Cristaudo Rudy Foddis Alessandra Bonotti Silvia Simonini Agnese Vivaldi Giovanni Guglielmi Rossella Bruno Debora Landi Federica Gemignani Stefano Landi

Occup Environ Med 2010 Apr 26;67(4):233-6. Epub 2009 Oct 26.

Department of Endocrinology and Metabolism, Orthopaedics and Traumatology, Occupational Medicine, University of Pisa, via Paradisa, 2 Pisa 56124, Italy.

View Article

April 2010

DeltaN133p53 expression levels in relation to haplotypes of the TP53 internal promoter region.

Authors:

Ilaria Bellini Letizia Pitto Maria G Marini Loredana Porcu Paolo Moi Sonia Garritano Laura Boldrini Giuseppe Rainaldi Gabriella Fontanini Massimo Chiarugi Roberto Barale Federica Gemignani Stefano Landi

Hum Mutat 2010 Apr;31(4):456-65

Department of Biology, University of Pisa, Via Derna 1, Pisa, Italy.

View Article

April 2010

Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect.

Authors:

Sonia Garritano Federica Gemignani Edenir Inez Palmero Magali Olivier Ghyslaine Martel-Planche Florence Le Calvez-Kelm Laurence Brugiéres Fernando Regla Vargas Ricardo Renzo Brentani Patricia Ashton-Prolla Stefano Landi Sean V Tavtigian Pierre Hainaut Maria Isabel W Achatz

Hum Mutat 2010 Feb;31(2):143-50

International Agency for Research on Cancer (IARC), Lyon, Rhône, France.

View Article

February 2010

Risk of malignant pleural mesothelioma and polymorphisms in genes involved in the genome stability and xenobiotics metabolism.

Authors:

Federica Gemignani Monica Neri Fabio Bottari Roberto Barale Pier Aldo Canessa Federico Canzian Marcello Ceppi Irene Spitaleri Monica Cipollini Gian Paolo Ivaldi Manlio Mencoboni Paola Scaruffi Gian Paolo Tonini Donatella Ugolini Luciano Mutti Stefano Bonassi Stefano Landi

Mutat Res 2009 Dec 12;671(1-2):76-83. Epub 2009 Sep 12.

Genetics - Department of Biology, University of Pisa, Via Derna, 1, 56100 Pisa, Italy.

View Article

December 2009

Pooled analysis of NAT2 genotypes as risk factors for asbestos-related malignant mesothelioma.

Authors:

Marta Betti Monica Neri Daniela Ferrante Stefano Landi Alessandra Biava Federica Gemignani Marinella Bertolotti Dario Mirabelli Marina Padoan Donatella Ugolini Mario Botta Stefano Bonassi Corrado Magnani Irma Dianzani

Int J Hyg Environ Health 2009 May 1;212(3):322-9. Epub 2008 Oct 1.

Department of Medical Sciences, University of Piemonte Orientale, Via Solaroli 17, 28100 Novara, Italy.

View Article

May 2009

Determining the effectiveness of High Resolution Melting analysis for SNP genotyping and mutation scanning at the TP53 locus.

Authors:

Sonia Garritano Federica Gemignani Catherine Voegele Tú Nguyen-Dumont Florence Le Calvez-Kelm Deepika De Silva Fabienne Lesueur Stefano Landi Sean V Tavtigian

BMC Genet 2009 Feb 17;10. Epub 2009 Feb 17.

Department of Biology, Genetics via Derna 1, University of Pisa, Pisa, Italy.

View Article

February 2009

Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases.

Authors:

Monica Neri Donatella Ugolini Irma Dianzani Federica Gemignani Stefano Landi Alfredo Cesario Corrado Magnani Luciano Mutti Riccardo Puntoni Stefano Bonassi

Mutat Res 2008 Jul-Aug;659(1-2):126-36. Epub 2008 Feb 23.

Unit of Molecular Epidemiology, National Cancer Research Institute, Genoa, Italy.

View Article

September 2008

Genetic susceptibility to malignant mesothelioma and exposure to asbestos: the influence of the familial factor.

Authors:

Donatella Ugolini Monica Neri Marcello Ceppi Alfredo Cesario Irma Dianzani Rosangela Filiberti Federica Gemignani Stefano Landi Corrado Magnani Luciano Mutti Riccardo Puntoni Stefano Bonassi

Mutat Res 2008 Mar-Apr;658(3):162-71. Epub 2007 Aug 10.

Dipartimento di Oncologia, Biologia e Genetica, University of Genoa, Genoa, Italy.

View Article

July 2008

DNA microarray based on arrayed-primer extension technique for identification of pathogenic fungi responsible for invasive and superficial mycoses.

Authors:

Daniele Campa Arianna Tavanti Federica Gemignani Crocifissa S Mogavero Ilaria Bellini Fabio Bottari Roberto Barale Stefano Landi Sonia Senesi

J Clin Microbiol 2008 Mar 26;46(3):909-15. Epub 2007 Dec 26.

Dipartimento di Biologia, Sezione di Genetica, Università di Pisa, Pisa, Italy.

View Article

March 2008

Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer.

Authors:

Debora Landi Federica Gemignani Alessio Naccarati Barbara Pardini Pavel Vodicka Ludmila Vodickova Jan Novotny Asta Försti Kari Hemminki Federico Canzian Stefano Landi

Carcinogenesis 2008 Mar 12;29(3):579-84. Epub 2008 Jan 12.

Dipartimento di Biologia, University of Pisa, Via Derna, 1, 56126 Pisa, Italy.

View Article

March 2008

A catalog of polymorphisms falling in microRNA-binding regions of cancer genes.

Authors:

Debora Landi Federica Gemignani Roberto Barale Stefano Landi

DNA Cell Biol 2008 Jan;27(1):35-43

Department of Biology, University of Pisa, Pisa, Italy.

View Article

January 2008

Development of a sensitive and specific multiplex PCR method combined with DNA microarray primer extension to detect Betapapillomavirus types.

Authors:

Tarik Gheit Gaëlle Billoud Maurits N C de Koning Federica Gemignani Ola Forslund Bakary S Sylla Salvatore Vaccarella Silvia Franceschi Stefano Landi Wim G V Quint Federico Canzian Massimo Tommasino

J Clin Microbiol 2007 Aug 20;45(8):2537-44. Epub 2007 Jun 20.

International Agency for Research on Cancer, Lyon, France.

View Article

August 2007

Development of lung cancer before the age of 50: the role of xenobiotic metabolizing genes.

Carcinogenesis 2007 Jun 27;28(6):1287-93. Epub 2007 Jan 27.

Genetics, Department of Biology, University of Pisa, Pisa, Italy.

View Article

June 2007

Polymorphisms of glutathione-S-transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesothelioma.

Authors:

Stefano Landi Federica Gemignani Monica Neri Roberto Barale Stefano Bonassi Fabio Bottari Pier Aldo Canessa Federico Canzian Marcello Ceppi Rosangela Filiberti Gian Paolo Ivaldi Manlio Mencoboni Paola Scaruffi Gian Paolo Tonini Luciano Mutti Riccardo Puntoni

Int J Cancer 2007 Jun;120(12):2739-43

Department of Biology, University of Pisa, Pisa, Italy.

View Article

June 2007

Interleukin-4 and interleukin-4 receptor polymorphisms and colorectal cancer risk.

Authors:

Stefano Landi Fabio Bottari Federica Gemignani Lydie Gioia-Patricola Elisabeth Guino Alfonso Osorio Javier de Oca Gabriel Capella Federico Canzian Victor Moreno

Eur J Cancer 2007 Mar 26;43(4):762-8. Epub 2007 Jan 26.

Genetics - Department of Biology, University of Pisa, via S. Giuseppe 22, 56126, Pisa, Italy.

View Article

March 2007

DNA repair and cell cycle control genes and the risk of young-onset lung cancer.

Cancer Res 2006 Nov;66(22):11062-9

Dip. Biologia-Genetics, University of Pisa, Pisa, Italy.

View Article

November 2006

Polymorphisms within inflammatory genes and colorectal cancer.

Authors:

Stefano Landi Federica Gemignani Fabio Bottari Lydie Gioia-Patricola Elisabet Guino María Cambray Sebastiano Biondo Gabriel Capella Laura Boldrini Federico Canzian Victor Moreno

J Negat Results Biomed 2006 Oct 24;5:15. Epub 2006 Oct 24.

Genetics-Department of Biology, University of Pisa, via S, Giuseppe 22, 56126, Pisa, Italy.

View Article

October 2006

Single tube genotyping of GSTM1, GSTT1 and TP53 polymorphisms by multiplex PCR.

Authors:

Fabio Bottari Stefano Landi Federica Gemignani

DNA Seq 2006 Oct;17(5):396-9

University of Pisa, Dipartimento di Biologia, Genetica, via S. Giuseppe 22, 56126, Pisa, Italy.

View Article

October 2006

Sequence variants in cell cycle control pathway, X-ray exposure, and lung cancer risk: a multicenter case-control study in Central Europe.

Authors:

Rayjean J Hung Paolo Boffetta Federico Canzian Norman Moullan Neonila Szeszenia-Dabrowska David Zaridze Jolanta Lissowska Peter Rudnai Eleonora Fabianova Dana Mates Lenka Foretova Vladimir Janout Vladimir Bencko Amelie Chabrier Stefano Landi Federica Gemignani Janet Hall Paul Brennan

Cancer Res 2006 Aug;66(16):8280-6

IARC, Lyon, France.

View Article

August 2006

Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types.

Authors:

Tarik Gheit Stefano Landi Federica Gemignani Peter J F Snijders Salvatore Vaccarella Silvia Franceschi Federico Canzian Massimo Tommasino

J Clin Microbiol 2006 Jun;44(6):2025-31

Infections and Cancer Biology Group, International Agency for Research on Cancer, 150, cours Albert-Thomas, 69372 Lyon, France.

View Article

June 2006

Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer.

Authors:

Victor Moreno Federica Gemignani Stefano Landi Lydie Gioia-Patricola Amélie Chabrier Ignacio Blanco Sara González Elisabet Guino Gabriel Capellà Federico Canzian

Clin Cancer Res 2006 Apr;12(7 Pt 1):2101-8

Institut d'Investigació Biomèdica de Bellvitge, Institut Catala d'Oncologia, Hospitalet, Barcelona, Spain.

View Article

April 2006

Effect of cruciferous vegetables on lung cancer in patients stratified by genetic status: a mendelian randomisation approach.

Authors:

Paul Brennan Charles C Hsu Norman Moullan Neonilia Szeszenia-Dabrowska Jolanta Lissowska David Zaridze Peter Rudnai Eleonora Fabianova Dana Mates Vladimir Bencko Lenka Foretova Vladimir Janout Federica Gemignani Amelie Chabrier Janet Hall Rayjean J Hung Paolo Boffetta Federico Canzian

Lancet 2005 Oct 29-Nov 4;366(9496):1558-60

International Agency for Research on Cancer, Lyon, France.

View Article

December 2005

A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer.

Authors:

Stefano Landi Federica Gemignani Victor Moreno Lydie Gioia-Patricola Amélie Chabrier Elisabeth Guino Matilde Navarro Javier de Oca Gabriel Capellà Federico Canzian

Pharmacogenet Genomics 2005 Aug;15(8):535-46

Genetica, Dip. Scienze Uomo e Ambiente, University of Pisa, Italy.

View Article

August 2005

Polymorphisms of the dopamine receptor gene DRD2 and colorectal cancer risk.

Authors:

Federica Gemignani Stefano Landi Victor Moreno Lydie Gioia-Patricola Amélie Chabrier Elisabet Guino Matilde Navarro Maria Cambray Gabriel Capellà Federico Canzian

Cancer Epidemiol Biomarkers Prev 2005 Jul;14(7):1633-8

International Agency for Research on Cancer, Lyon, France.

View Article

July 2005

A database of single-nucleotide polymorphisms and a genotyping microarray for genetic epidemiology of lung cancer.

Authors:

Stefano Landi Federica Gemignani Stéphanie Monnier Federico Canzian

Exp Lung Res 2005 Mar;31(2):223-58

Dipartimento di Scienze dell'Uomo e dell' Ambiente, Genome Research Group, University of Pisa, Pisa, Italy.

View Article

March 2005

Generation of a DNA microarray for determination of E6 natural variants of human papillomavirus type 16.

Authors:

Federica Gemignani Stefano Landi Amélie Chabrier Anouk Smet Ingeborg Zehbe Federico Canzian Massimo Tommasino

J Virol Methods 2004 Aug;119(2):95-102

International Agency for Research on Cancer, World Health Organization, 150 Cours Albert Thomas, 69372 Lyon Cedex 08, France.

View Article

August 2004

A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA.

Authors:

Federica Gemignani Victor Moreno Stefano Landi Norman Moullan Amélie Chabrier Sara Gutiérrez-Enríquez Janet Hall Elisabeth Guino Miguel Angel Peinado Gabriel Capella Federico Canzian

Oncogene 2004 Mar;23(10):1954-6

International Agency for Research on Cancer, Lyon 69372, France.

View Article

March 2004

Evaluation of a microarray for genotyping polymorphisms related to xenobiotic metabolism and DNA repair.

Authors:

Stefano Landi Federica Gemignani Lydie Gioia-Patricola Amélie Chabrier Federico Canzian

Biotechniques 2003 Oct;35(4):816-20, 822, 824-7

International Agency for Research on Cancer, Lyon, France.

View Article

October 2003

High-level expression of hemoglobin A in human thalassemic erythroid progenitor cells following lentiviral vector delivery of an antisense snRNA.

Authors:

Marla M Vacek Hong Ma Federica Gemignani Giuseppina Lacerra Tal Kafri Ryszard Kole

Blood 2003 Jan 15;101(1):104-11. Epub 2002 Aug 15.

Curriculum in Genetics and Molecular Biology, University of North Carolina Gene Therapy Center, Department of Pharmacology and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, 27599, USA.

View Article

January 2003

Systemically delivered antisense oligomers upregulate gene expression in mouse tissues.

Authors:

Peter Sazani Federica Gemignani Shin-Hong Kang Martin A Maier Muthiah Manoharan Magnus Persmark Donna Bortner Ryszard Kole

Nat Biotechnol 2002 Dec 11;20(12):1228-33. Epub 2002 Nov 11.

Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA.

View Article

December 2002

Reliable detection of beta-thalassemia and G6PD mutations by a DNA microarray.

Authors:

Federica Gemignani Chiara Perra Stefano Landi Federico Canzian Ants Kurg Neeme Tõnisson Renzo Galanello Antonio Cao Andres Metspalu Giovanni Romeo

Clin Chem 2002 Nov;48(11):2051-4

IARC, International Agency for Research on Cancer, 150, Cours Albert Thomas, Lyon 69372, France.

View Article

November 2002

Temperature-dependent splicing of beta-globin pre-mRNA.

Authors:

Federica Gemignani Peter Sazani Paul Morcos Ryszard Kole

Nucleic Acids Res 2002 Nov;30(21):4592-8

Lineberger Comprehensive Cancer Center and Department of Pharmacology, CB 7295, University of North Carolina, Chapel Hill, NC 27599-7295, USA.

View Article

November 2002

A catalogue of polymorphisms related to xenobiotic metabolism and cancer susceptibility.

Authors:

Federica Gemignani Stefano Landi Franck Vivant Shanbeh Zienolddiny Paul Brennan Federico Canzian

Pharmacogenetics 2002 Aug;12(6):459-63

Genome Analysis Group, International Agency for Research on Cancer, Lyon, France.

View Article

August 2002

Formation of micronuclei and of clastogenic factor(s) in patients receiving therapeutic doses of iodine-131.

Authors:

Michela Ballardin Federica Gemignani Lisa Bodei Giuliano Mariani Marco Ferdeghini Anna Maria Rossi Lucia Migliore Roberto Barale

Mutat Res 2002 Feb;514(1-2):77-85

Dipartimento di Scienze dell'Uomo e dell'Ambiente, University of Pisa, Pisa, Italy.

View Article

February 2002

Federica Gemignani

Federica Gemignani

Publications by authors named "Federica Gemignani"

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors: